Azusa Nagao

Long‐term safety and efficacy of rIX‐FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B

Maria Elisa Mancuso, Aaron Lubetsky, Brigitte Pan‐Petesch et al. · Journal of Thrombosis and Haemostasis · 2020 · 44 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Clinical outcomes in hemophilia A patients undergoing tailoring of prophylaxis based on population-based pharmacokinetic dosing

Azusa Nagao, Cindy H. T. Yeung, Federico Germini et al. · Thrombosis Research · 2018 · 43 citations

Pharmacy, Hematology, Pharmacokinetics +12

Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients’ perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A

Midori Shima, Azusa Nagao, Masashi Taki et al. · Haemophilia · 2020 · 38 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients

Donna Coffin, Emma Gouider, Barbara A. Konkle et al. · Research and Practice in Thrombosis and Haemostasis · 2023 · 38 citations · Full text

Medicine, Hematology, Clinical Epidemiology +10

Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases

Azusa Nagao, Shoko Nakazawa, Hideji Hanabusa · Journal of Hematology & Oncology · 2014 · 31 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15